| Product Code: ETC7645368 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Autoimmune Disorders Treatment Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Autoimmune Disorders Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Autoimmune Disorders Treatment Market - Industry Life Cycle |
3.4 Israel Autoimmune Disorders Treatment Market - Porter's Five Forces |
3.5 Israel Autoimmune Disorders Treatment Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Autoimmune Disorders Treatment Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Israel Autoimmune Disorders Treatment Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Israel Autoimmune Disorders Treatment Market Revenues & Volume Share, By Service, 2021 & 2031F |
4 Israel Autoimmune Disorders Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune disorders in Israel |
4.2.2 Advancements in medical technology and treatment options for autoimmune disorders |
4.2.3 Growing awareness and focus on healthcare among the population in Israel |
4.3 Market Restraints |
4.3.1 High treatment costs associated with autoimmune disorders |
4.3.2 Limited access to specialized healthcare services in certain regions of Israel |
4.3.3 Stringent regulatory requirements for approval of autoimmune disorder treatments |
5 Israel Autoimmune Disorders Treatment Market Trends |
6 Israel Autoimmune Disorders Treatment Market, By Types |
6.1 Israel Autoimmune Disorders Treatment Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Therapeutic drug Products, 2021- 2031F |
6.1.4 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Therapeutic equipment, 2021- 2031F |
6.2 Israel Autoimmune Disorders Treatment Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Bridge therapy, 2021- 2031F |
6.2.3 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Recombinant technology, 2021- 2031F |
6.2.4 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Fecal bacteriotherapy, 2021- 2031F |
6.2.5 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Hematopoietic stem-cell transplantation, 2021- 2031F |
6.2.6 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Phototherapy, 2021- 2031F |
6.2.7 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Helminthic therapy, 2021- 2031F |
6.2.8 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Cytometry by time-of-flight mass spectrometry, 2021- 2031F |
6.2.9 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Cytometry by time-of-flight mass spectrometry, 2021- 2031F |
6.3 Israel Autoimmune Disorders Treatment Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Systemic autoimmune diseases (involve several organs of the body), 2021- 2031F |
6.3.3 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Localized autoimmune diseases (involve single organ), 2021- 2031F |
6.4 Israel Autoimmune Disorders Treatment Market, By Service |
6.4.1 Overview and Analysis |
6.4.2 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Consultation & Diagnosis, 2021- 2031F |
6.4.3 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Therapy & Monitoring, 2021- 2031F |
6.4.4 Israel Autoimmune Disorders Treatment Market Revenues & Volume, By Drug Development, 2021- 2031F |
7 Israel Autoimmune Disorders Treatment Market Import-Export Trade Statistics |
7.1 Israel Autoimmune Disorders Treatment Market Export to Major Countries |
7.2 Israel Autoimmune Disorders Treatment Market Imports from Major Countries |
8 Israel Autoimmune Disorders Treatment Market Key Performance Indicators |
8.1 Average time from diagnosis to treatment initiation for autoimmune disorders |
8.2 Patient satisfaction with autoimmune disorder treatment options |
8.3 Number of clinical trials and research studies conducted on autoimmune disorders in Israel |
9 Israel Autoimmune Disorders Treatment Market - Opportunity Assessment |
9.1 Israel Autoimmune Disorders Treatment Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Autoimmune Disorders Treatment Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 Israel Autoimmune Disorders Treatment Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Israel Autoimmune Disorders Treatment Market Opportunity Assessment, By Service, 2021 & 2031F |
10 Israel Autoimmune Disorders Treatment Market - Competitive Landscape |
10.1 Israel Autoimmune Disorders Treatment Market Revenue Share, By Companies, 2024 |
10.2 Israel Autoimmune Disorders Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here